Bernard Grose
Physician Assistant · Saint Albans, WVNPI 1790087187
Payments from drug & device makers
Across 161 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$606
- AbbVie$562
- Corium, LLC$541
- Alkermes, Inc.$411
- Otsuka America Pharmaceutical, Inc.$222
- Novo Nordisk$141
- plus $527 from 14 others
What the payments were for
- Food & beverage$3,010100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 32 | $606 |
| AbbVie | 31 | $562 |
| Corium, LLC | 32 | $541 |
| Alkermes, Inc. | 25 | $411 |
| Otsuka America Pharmaceutical, Inc. | 7 | $222 |
| Novo Nordisk | 8 | $141 |
| Lundbeck LLC | 5 | $102 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Neurocrine Biosciences, Inc. | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| Merck | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Exact Sciences | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Abbott | 1 | $20 |
| Pfizer | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,010 in reported general payments places this provider in the 90th percentile of 833 physician assistant providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 54 | $101,602 |
| VraylarCariprazine Hcl | 21 | $41,900 |
| Lurasidone Hcl | 105 | $35,303 |
| TrintellixVortioxetine Hydrobromide | 17 | $15,915 |
| Aripiprazole | 125 | $4,787 |
| Ziprasidone Hcl | 45 | $3,173 |
| Trazodone Hcl | 128 | $2,984 |
| Quetiapine Fumarate | 147 | $2,833 |
| Oxcarbazepine | 43 | $1,822 |
| Clonazepam | 225 | $1,680 |
| Buspirone Hcl | 90 | $1,539 |
| Olanzapine | 21 | $1,194 |
| Lamotrigine | 55 | $1,070 |
| Fluoxetine Hcl | 87 | $896 |
| Bupropion XlBupropion Hcl | 31 | $847 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $222 | $101,60254 claims |
| AbbVieVraylar | $562 | $41,90021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Saint Albans
- Tina BeattySaint Albans$5K
- Amy ButtsWellsburg$258K
- Alexander EpperlySouth Charleston$21K
- Kelley WhoolerySouth Charleston$17K
- Jordan BrewerMorgantown$15K
- Tasha ElswickWinfield$14K
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Erik AndersonSouth Charleston$11K
- Catherine EnsingerParkersburg$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.